
Drug Target Models
GPCR Reporter Cells
Immunotherapy cells
Other Stable Cells
Assay Kits & Reagents
Services
Resources
Company
Cat. No: RQP74490
Size: 1 vial of frozen cells (>1E6 per vial in 1 mL)
Unit Price: Contact For Pricing
| Cat. No | RQP74490 |
| Product Name | CHO-K1 Human ICOSL aAPC Cell |
| Product Type | Reporter Cell |
| Culture Properties | Adherent |
| Stability | 32passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Mycoplasma Status | Negative |
| Culture Medium | F12K+10%FBS+ 3 μg/ml Puromycin+600 μg/ml Hygromycin B |
| Freeze Medium | 90% FBS+10% DMSO |
| Storage Conditions | Liquid nitrogen immediately upon delivery |
| Application | Functional(Report Gene) Assay |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
ICOS is a co-stimulatory receptor that is induced upon T-cell activation, while ICOSL is its ligand, which is primarily constitutively expressed on the surface of B cells and antigen-presenting cells. The core mechanism of action for both lies in the fact that when activated T cells (particularly follicular helper T cells) migrate to lymphoid follicles and encounter B cells, the binding of ICOS to ICOSL provides a critical co-stimulatory signal to the T cells, This primarily occurs through the activation of downstream pathways such as PI3K, driving T-cell proliferation, survival, and cytokine production (e.g., IL-21), thereby precisely regulating the germinal center response. Ultimately, this promotes antibody affinity maturation and class switching in B cells, leading to the generation of highly effective humoral immunity.
ICOSL aAPC CHO, as the target cell for the ICOS Effector Reporter Cell, effectively mimics the in vivo ICOS signaling pathway; the mechanism is illustrated in the figure below.

Figure 1. ICOSL aAPC CHO 细胞模型原理图
| Classification | Co-Stimulatory |
| Family | B7 family |
| Gene Name | ICOSLG |
| Gene Aliases | ICOSL;ICOS-L;KIAA0653;GL50;B7-H2;B7RP-1;B7H2;B7RP1;CD275;B7h |
| Gene ID | 23308 |
| Accession Number | NM_015259.6 |
| UniProt Number | O75144 |
| Protein Name | ICOS ligand |
| Protein Aliases | B7-H2;B7-like protein Gl50;B7RP-1 |
| Target Species | Human |
| Host cell | CHO-K1 |

Figure 2. Recombinant ICOSL aAPC CHO stably expressing ICOSL.

Cell Resuscitation
1)Rapidly thaw the frozen cells in a 37 °C water bath for approximately 60 seconds. Once thawed (which may take slightly less or more than 60 seconds), immediately transfer the cell suspension from the cryovial into a 15 mL centrifuge tube containing 10 mL of pre-warmed CHO-K1 Human ICOSL aAPC Cell complete culture medium.
2)Centrifuge cells at 1000 rpm for 5 min to remove medium, then resuspend cells in 5 mL of pre-warmed complete medium.
3)Transfer the cell suspension into a T25 culture flask and incubate at 37 °C with 5% CO₂.
4)After approximately 24–36 hours, replace the medium or passage the cells to remove non-adherent dead cells.
Subculturing procedure
1)When the cell density reaches the appropriate confluency for passaging, wash the cells with PBS, then add 1 mL trypsin to detach the cells. When more than 80% of the cells detach upon gently tapping the culture flask, add complete culture medium to terminate digestion. Gently pipette to obtain a single-cell suspension, transfer to a 15 mL centrifuge tube, and centrifuge at 1000 rpm for 5 minutes.
2)Discard supernatant after centrifugation. Resuspend cells in fresh medium to a single-cell suspension and transfer to a new culture flask for continued growth.
Cell Freezing
After trypsinization and centrifugation of cells from each T75 flask or 10 cm culture dish, discard the supernatant. Add 2 mL of cryopreservation medium (90% FBS + 10% DMSO), gently resuspend thoroughly, and aliquot into two cryovials. Immediately place the cryovials into a controlled-rate freezing container (e.g., Nalgene 5100-0001), fill with isopropanol to the indicated level, and store at −80 °C. After 24 hours, transfer the cryovials to liquid nitrogen for long-term storage.
We Are Pleased to Announce: Global Commercial Licensing Rights for Jurkat E6.1, CHO-K1, and HEK293 Cell Lines Officially Secured.
Explore